Clinical trial NCT05534542: Comparison of the Effectiveness of Intradialytic Core Stabilization and Aerobic Exercise in Hemodialysis Patients
Official title: Comparison of the Effectiveness of Intradialytic Core Stabilization and Aerobic Exercise in Hemodialysis Patients
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Hemodialysis Complication
Keywords: hemodialysis
dialysis efficiency
fatigue
quality of life
sleep
functionality
Lead sponsor: Muş Alparslan University
Sponsor class: OTHER
First posted: 2022-09-09
Enrollment: 40
Sex: ALL
Minimum age (years): 18
Maximum age (years): 80
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: Purpose: To examine the effects of core stabilization and aerobic exercises on dialysis adequacy, functionality level, and quality of life in hemodialysis (HD) patients. The secondary aim of the study is to compare the effectiveness of intradialytic core stabilization and aerobic exercises in HD patients.

Materials and Methods: Patients who received hemodialysis treatment for 4 hours, 3 days a week were planned to be included in this randomized controlled study. Patients participating in the study will be randomly divided into 2 groups. Grup 1 was planned to be given core stabilization exercises during hemodialysis three times a week for eight weeks; Group 2 was planned to be given aerobic exercise during hemodialysis three times a week for eight weeks. It aimed to evaluate the patients in the weeks before the start of the treatment and the week after the end of the treatment. Personal information form for evaluation, dialysis adequacy, quality of life questionnaire-kidney disease quality of life-36, piper fatigue scale, hospital anxiety and depression scale (hads), Pittsburgh sleep scale, five times sit and stand test, 10 m walking test , tinetti balance and walking test, and 2-minute step test were planned to be used.


Eligibility criteria: Inclusion Criteria:

* To receive HD treatment for a minimum of 6 months, for 4 hours per day, three days per week
* Being 18 years or older
* A score of 3 and/or below in the Sarcopenia Screening Test (SARC-F)

Exclusion Criteria:

* Having a history of myocardial infarction in the last 3 months
* Having angina pectoris, arrhythmia, or uncontrolled hypertension
* Having communication and/or cognitive issues that prevent them from meeting the requirements of the tests
* Becoming pregnant or going through infertility treatment
* Having a psychiatric diagnosis

Primary outcomes:
measure: Dialysis adequacy
timeFrame: one month
measure: Kidney Disease Quality of Life-36 (KDQOL-36)
timeFrame: Two months
measure: Five times sit-to-stand test
timeFrame: Two months
measure: 2 Minute Step Test
timeFrame: Two months
measure: 10 Metre Walk Test
timeFrame: Two months
Secondary outcomes:
measure: Piper Fatigue Scale
timeFrame: Two months
measure: Hospital Anxiety and Depression Scale (HADS)
timeFrame: Two months
measure: Pittsburgh Sleep Quality Index (PSQI)
timeFrame: Two months
measure: Tinetti Gait and Balance Test
timeFrame: Two months
Other outcomes:
Locations:
city: Muş
country: Turkey
facility: Mus State Hospital
state: Mus
Study officials:
affiliation: scholar
name: Cengiz TAŞKAYA
role: PRINCIPAL_INVESTIGATOR
affiliation: scholar
name: Buket Büyükturan
role: STUDY_DIRECTOR
References: